Because of a few poignant questions on yesterday's significant Queensland Bauxite announcement there are dominating queries sent to the Company that obviously need clarification. On behalf of the Queensland Bauxite Board I would like to answer and clarify these questions, so that shareholders fully understand the Announcement and its implications for QBL. Question 1). Because the new deal almost doubles the share capital [...]
Pnina Feldman's Queensland Bauxite has announced today that QBL is undertaking a significant transformation of the Company from a mining exploration company with a Medical Cannabis subsidiary to a new major global Cannabis player through a 100% merger of its 55% owned subsidiary, Medical Cannabis Limited and the new 100% acquisition of Medcan Australia. The 100% merger of MCL and QBL, which is expected to be approved by [...]
The Board of Queensland Bauxite is excited to announce that the Company and its subsidiary, Medical Cannabis Limited have entered into a legally binding heads of agreement to acquire a 100% interest in Medcan Australia Pty Ltd . Medcan is the holder of an Office of Drug Control Medical Cannabis Production License with an experienced management and production team with a contract to supply already in place, which enables [...]
The Board of Queensland Bauxite is delighted to announce that the ASX has approved the Company's Announcement to be released. The Company intends to release the announcement on Thursday 21 June 2018. QBL will recommence trading on the ASX following the release of the Announcement. The Board would like to thank our shareholders for their patience and support during this process. The Board also appreciates the guidance and [...]
Queensland Bauxite provides the Company's Quarterly Activities Report. EXECUTIVE CHAIRPERSON'S REPORT I am very pleased to report, as QBL's Executive Chairperson and responsible for Business Development, on behalf of the Board of Queensland Bauxite Ltd. our most significant Quarterly to date. We are currently in the midst of an international expansion project that has taken Queensland Bauxite Ltd. from purely an [...]
Members of the Queensland Bauxite management team responsible for the development of the South Johnstone Bauxite Project, headed by QBL's Chief Geoscientist Dr Robert Coenraads PhD, as part of its ongoing marketing strategy, and as part of the operational plan under the existing granted Mineral Development Licence on South Johnstone, are currently visiting several Chinese bauxite refineries and aluminium smelters whose [...]
The Board of Queensland Bauxite is delighted to announce that its subsidiary, Medical Cannabis Limited has entered into a binding MOU with Burleigh Heads Cannabis. BHC has a medical cannabis import license approved by the Office of Drug Control, and has Government approved secure storage facilities for medical cannabis products. The MOU outlines the terms where BHC will provide the import and storage services for MCL's [...]
The Board of Queensland Bauxite is pleased to advise that Red Tractor have now supplied hundreds of Coles stores around Australia with various products and oil blends that have hemp ingredients included exclusively supplied by QBL's subsidiary Medical cannabis Limited and its hemp seed food subsidiary VitaHemp Pty Ltd . Exposing Hemp Foods to a mass consumer market who may know little about Hemp, and now see Hemp derived [...]
The Board of Queensland Bauxite are pleased to advise that Medical Cannabis Limited through its subsidiary VitaHemp Pty Ltd , has announced the release of a very first to market, Australian grown and processed Hemp Seed Oil soft-gel capsules. Over the past week, three of VitaHemp's new "Black label" products have been launched on VitaHemp's website www.vitahemp.com More and more Australians understand a correlation [...]
The Board of Queensland Bauxite is pleased to advise that Medical Cannabis Limited through its subsidiary VitaHemp, is announcing the release of a first of its kind to the Australian market, Australian grown and processed Hemp Seed Oil soft-gel capsules. These capsules meet a unique consumer demand in the Australian market. More and more Australians understand a correlation between diet and general well-being. Omega 3-6-9 [...]
The board of Queensland Bauxite is pleased to update the market on developments in the drug development strategy for its subsidiary, Medical Cannabis Limited . MCL, in conjunction with Certara, a pharmaceutical consulting firm, have developed a drug development strategy for the distribution of Canntab XR medication in the Australian market. The Certara team includes Dr Andreas Wallnoefer, who held a significant tenure as [...]
The Board of Queensland Bauxite is pleased to advise that it has cleared the company's outstanding debt by way of share issue. The liability of the Company which has been settled with this share issue, was pursuant to a financing agreement entered into by the Company over a year ago with New York based investment and finance company MEF I L.P. which was entered into at the time in order to enable the Company to take up [...]
